Freely Filtered

DocwireNews-nonprod

<p><em>Freely Filtered</em> discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.</p>


DDAVP Up the Nose to Prevent Biopsy Bleeding

Nephrology Times

Leah Lawrence

Crohn’s Disease Linked With Asthma

Asthma

Hope Rugo, MD

SERENA-6 at ASCO 2025: ctDNA-Guided Therapy in HR+/HER2- mBC

HR Breast Cancer

Latest News

REGENCY

The Freely Filtered podcast discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.

REGENCY (Freely Filtered, Ep. 79)

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

HER2 Breast Cancer

HR+/HER2- Breast Cancer Learning Lab

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Inflammatory Bowel Disease

Irritable Bowel Syndrome

Hepatitis

Gastro Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Diabetes

Obesity

Metabolic Care Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Sleep

Career News

Future of Medicine

Health and Wellness

— HIV

Infectious Diseases

Lupus

Neurology

Oncology

Ophthalmology

— Demodex Blepharitis

Orthopedics

Pharmacology

Pulmonology

Rheumatology

Urology

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Practice Tips With Dr. Lichaa

Partners

Expert Interviews

Subscribe

REGENCY

Related Podcasts